Testing Choices: From the standard to the extraordinary
Test | Test Name |
---|---|
0719B | Bromazolam, Blood |
0719SP | Bromazolam, Serum/Plasma |
0719U | Bromazolam (Qualitative), Urine |
0771B | Brorphine, Blood |
0771SP | Brorphine, Serum/Plasma |
0771U | Brorphine, Urine |
0803B | Bupropion and Metabolite, Blood |
0803FL | Bupropion and Metabolite, Fluid |
0803SP | Bupropion and Metabolite, Serum/Plasma |
0803TI | Bupropion and Metabolite, Tissue |
0803U | Bupropion and Metabolite, Urine |
2626B | Bath Salts Panel (Qualitative), Blood |
2626SP | Bath Salts Panel (Qualitative), Serum/Plasma |
2626U | Bath Salts Panel (Qualitative), Urine |
9122B | Bupropion and Metabolite Screen, Blood |
9122SP | Bupropion and Metabolite Screen, Serum/Plasma |
9122TI | Bupropion and Metabolite Screen, Tissue |
9122U | Bupropion and Metabolite Screen, Urine |
9329ME | Benzodiazepines Panel (Qualitative), Meconium |
9351UC | Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |